🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Gotta see the #ASCO24 therapy dog!

.gilberto lopes Getting ready for our educational session on how social media advances and promotes professional development. #ASCO24

Thanks to Twitter, I’m “attending” ASCO24 without attending.

Lovely day for a post-#ASCO24 walk! #chicago

Very grateful to be standing on the shoulders of giants. Truly humbled to be mentored by such inspiring, generous and kind physicians MD Anderson Cancer Center. Tapan Kadia Dr DiNardo Alex Bataller Naval Daver, M.D. Naveen Pemmaraju, MD Nitin Jain Hagop Kantarjian,MD Sanam Loghavi, MD صنم لغوی 🔬🧬 Lucia Masarova, MD #EHA24

Abishek Maiti from MD Anderson Cancer Center presenting at the #EHA2024 Late breaking abstract plenary session.

👉👉👉Phenomenal #Leukemia team to spend some time with discussing new ideas 💡 after clinic day ✔️ Eitan Kugler Akhil Jain Wei Ying Jen Jayastu Senapati Danielle Hammond, MD Naveen Pemmaraju, MD 👏 👏 👏 #endcancer #MPNSM #BPDCN #leusm #VEXAS | MD Anderson Cancer Center 🙏

For me, R R stands for relapsed/refractory 🤦 what about you? #leusm life of a #leukemia specialist 🙄

👉👉👉Day 3 #HurricaneBerryl. Many of us no power & no A/C still day #3 after major hurricane 🌀 hit Houston. #Inspired by #resilience of our patients, #caregivers & families & our #Leukemia clinic colleagues to join together - special place of #hope - MD Anderson Cancer Center #endcancer

Dr John Seymour giving Dr Michael Keating plenary award lecture at #SOHO24 Society of Hematologic Oncology (SOHO) First patient ever treated with venetoclax (previously called ABT-199) was in June 2011 in Australia with Dr Seymour. Amazing how this drug has changed the practice of leukemia care,

My friend went to Chimney Rock to help with the ground effort recovery. He just sent me videos. The town is gone. And this is what it looks like across dozens of mountain communities. Helene is officially the 2nd deadliest hurricane in the last 50 years.

NEWS: We are excited to announce that the first patient has been dosed in the Phase IIb/III VENETIAN trial to evaluate risk of TLS and optimize BCL2 initiation in patients with previously untreated #CLL. Learn more: bit.ly/3UwSX42

NEWS: AbbVie has recently published real-world data in #AJH evaluating BCL2i-based therapy after BTKi treatment in #CLL. For more information bit.ly/40Arfqk Toby Eyre, calliecoombs Alan Skarbnik Matthew Davids, MD, MMSc #leusm

On #WorldCancerDay we think & pray for ⤵️ 👨‍👩‍👧‍👦 Patients & families going though the cancer journey...never forget the light at the end of the tunnel 💡 🧑‍⚕️Healthcare workers, doctors, nurses, scientists, & every person caring for cancer patients OncoAlert #LetsBeatCancerTogether

Andrew Teletnick from UPMC Presbyterian presented on "Evaluating the Impact of a Standardized Protocol for Managing Refractory Vasoplegia After Cardiopulmonary Bypass"

Good Review Article on Vasoplegic Shock. bjaed.org/article/S2058-… Noteworthy points on last line agents in our arsenal for refractory Vasoplegia: Methylene Blue - Acts as a "nitric oxide scavenger" - Selectively causes vasoconstriction only in vasoplegic vessels - Can falsely

Can Angiotensin II be a used for vasoplegia in critical care? Our latest systematic review dives into the evidence 🩺💡 📉 Mortality impact remains unclear, but safety profile shines. A promising tool for refractory shock #Vasoplegia jcvaonline.com/article/S1053-…

Vasoplegia in Heart, Lung, & Liver Transplants: Key Insights for Saving Lives​​ 💔🫁🩺 💡 ​​Why It Matters?​​ Vasoplegia triples mortality risk in transplant patients. Early recognition and tailored management are ​​critical​​! jcvaonline.com/article/S1053-… @JCVA_Journal 🩺

Integrating #cardiovascular #biomarkers into perioperative sub-phenotyping can enhance #RiskStratification and management. Sub-phenotyping could refine risk prediction and help identify high-risk patients bjanaesthesia.org/article/S0007-…

Do you think you fully understand hemodynamics? Guess again. This MUST-READ paper illustrates the numerous parameters that should be evaluated when resuscitating a patient in shock. 🎩 tip to the authors. What a fantastic team of great people on this one. eddyjoemd.com/foamed